Request Information
Request Information
Oct 30 2018
ABC KSAT 12
CHICAGO (Ivanhoe Newswire) - Lung cancer kills more Americans than breast, prostate and colon cancer combined, and like other forms of cancer, the earlier it’s caught, the better chance patients have to survive. Now, a new device is helping doctors diagnose lung cancer in one minimally-invasive procedure.
This video created by Ivanhoe discusses the impact of the deadly disease, lung cancer, on a young women and her family. With no history of smoking, she never thought that she would get cancer. She shares her story as she battled cancer with the support of her family.
One challenge with lung cancer is reaching these tiny nodules while they are are still treatable. Often found deep in the lungs, physicians are challenged with today's manual bronchoscope.
With the introduction of the Monarch Platform featuring robotic bronchoscopy, physicians can skillfully drive deep into the lungs to reach very small tumors so they can be safely diagnosed. Physicians now have the tools to reach these new nodules using the natural orifices of the body.
Dr. Kyle Hogarth of the University of Chicago was an integral partner to Auris Health, providing clinical feedback during the development of this robotic technology.
Read the articleBronchoscopy:
Complications from bronchoscopy are rare and most often minor, but if they occur, may include breathing difficulty, vocal cord spasm, hoarseness, slight fever, vomiting, dizziness, bronchial spasm, infection, low blood oxygen, bleeding from biopsied site, or an allergic reaction to medications. Only rarely do patients experience other more serious complications (for example, collapsed lung, respiratory failure, heart attack and/or cardiac arrhythmia).
Urology:
Adverse effects from both Mini-PCNL and Ureteroscopy include pain, urinary tract infection, fever, hematuria (presence of blood in urine), exposure to low levels of radiation, retained or residual stones.
Adverse effects from ureteroscopy may include pain, perforation or injury to the ureter, resulting in extravasation of fluid and urine (urinoma), stricture of the ureter with risk of subsequent obstruction (hydronephrosis needing further repair), rare avulsion of the ureter, urinary blood clots, residual stones.
PCNL access may result in minor and major adverse effects. Minor effects include fever and nephrostomy leak. Major adverse effects may include injuries to pleura, liver, spleen, large vessels with related bleeding, gallbladder, duodenum, jejunum, colon with related cutaneous fistula, fever, pain, ileus, elevated counts.
Major adverse effects related to stone removal may include infection and urosepsis, intravascular fluid overload, extravasation of fluid, and post percutaneous nephrolithotomy bleeding.